91 results
DEFM14A
ISEE
IVERIC bio Inc
5 Jun 23
Proxy related to merger
8:54am
on Form 10-Q and Current Reports on Form 8-K. In addition, the Management Projections may be affected by IVERIC’s ability to achieve strategic goals … for whether the performance goals for such incentive have been met; and reimbursement for monthly COBRA premium payments to continue such coverage for up
DEFA14A
EX-99.1
ISEE
IVERIC bio Inc
1 Jun 23
Additional proxy soliciting materials
4:42pm
Exhibit 99.1
ISEE Transaction Employee Q&A
Can you go into more detail on how our corporate goals will change with the acquisition? I know the FAQs … say “business as usual” but it doesn’t seem like that. Will the pipeline, finance, legal and HR/comms goals get changed soon or by Astellas?
See FAQ
PREM14A
ISEE
IVERIC bio Inc
23 May 23
Preliminary proxy related to merger
6:49am
and Current Reports on Form 8-K. In addition, the Management Projections may be affected by IVERIC’s ability to achieve strategic goals, objectives … the performance goals for such incentive have been met; and reimbursement for monthly COBRA premium
payments to continue such coverage for up to 12
DEFA14A
t0m6 g6z5jec5
1 May 23
Additional proxy soliciting materials
4:11pm
DEFA14A
EX-99.1
n65trym
1 May 23
Additional proxy soliciting materials
7:05am
8-K
EX-99.1
xx1pno7o
1 May 23
Astellas Enters into Definitive Agreement
7:02am
8-K
jpszbzf
5 Dec 22
Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock
7:45am
424B5
u4xjf7
1 Dec 22
Prospectus supplement for primary offering
4:02pm
424B5
7pkqsyjs du2ajo6c8et
30 Nov 22
Prospectus supplement for primary offering
4:11pm